The BioFocus website uses cookies to store information on your computer, to improve our website. One of the cookies we use is essential for parts of the site to operate and has already been set. You may delete and block all cookies from this site, but parts of the site will not work. To find out more about the cookies we use and how to delete them, see our privacy notice.


I accept cookies from this site
 
Back

A decade of success

For the past 10 years, BioFocus has pioneered the field of rationally designed focused libraries through our SoftFocus brand. Our novel libraries, designed to target specific gene families, have proved immensely valuable to clients, generating potent and selective molecules at higher rates than other collections. This success has been shown through client publications and clinical candidates directly derived from compounds within the SoftFocus range – providing a level of success we are very proud of.

Client feedback and publications

“Novelty and highly focused design were the deciding factors in Galapagos screening BioFocus’ SoftFocus compounds. We were able to develop a hit series from the initial screen and nominate a pre-clinical candidate in a three year timeline”, Graham Dixon, SVP Drug Discovery, Galapagos.


Oyarzabal et al. Discovery of Mitogen-Activated Protein Kinase-Interacting Kinase 1 Inhibitors by a Comprehensive Fragment-Orientated Virtual Screening Approach. J. Med. Chem., 2010, 53 (18), pp 6618–6628.


Doudou et al,. Inhibitors of PIM-1 Kinase: A Computational Analysis of the Binding Free Energies of a Range of Imidazo [1,2-b] Pyridazines. J. Chem. Inf. Model., 2010, 50 (3), pp 368–379.


Simard et al. High-Throughput Screening To Identify Inhibitors Which Stabilize Inactive Kinase Conformations in p38α. J. Am. Chem. Soc., 2009, 131 (51), pp 18478–18488.


Niculescu-Duvaz et al. Novel Inhibitors of the v-raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) Based on a 2,6-Disubstituted Pyrazine Scaffold. J. Med. Chem., 2008, 51 (11), pp 3261–3274.


Sprous et al., Kinase inhibitor recognition by use of a multivariable QSAR model. Journal of Molecular Graphics & Modelling (2006), 24(4).


Bullock et al. Structural Basis of Inhibitor Specificity of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM-1) Kinase. J. Med. Chem., 2005, 48 (24), pp 7604–7614.


Baurin et al, Drug-like Annotation and Duplicate Analysis of a 23-Supplier Chemical Database Totalling 2.7 Million Compounds. J. Chem. Inf. Comput. Sci., 2004, 44 (2), pp 643–651.

 





Print to HTML Print as PDF Send to a friend




BioFocus®, SoftFocus®, Galapagos®, SilenceSelect® and FLeXSelect® ThemePair™, FieldFocus™, HDRA™. Helical Domain Recognition Analysis™, 2D Roadmap™, Thematic Analysis™, SFK™, SFI™, SFG™ and PrimePath™ are trademarks of Galapagos NV and/or its affiliates.